TOP STORIES
Jazz Pharmaceuticals has made a $1.5 billion offer for Celator to gain access to its drug Vyxeos, which is used to treat acute myeloid leukemia. Earlier this month, the U.S. Food and Drug Administration granted breakthrough therapy designation to Vyxeos. The deal reflects the continued dealflow in biotech. It also gives Jazz its third cancer drug. — The Wall Street Journal, Reuters
LIFE SCIENCES
The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]
MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.
SV Life Sciences has raised $274 million in what will be its sixth fund to invest in life sciences startups. — Boston Business Journal
Amicus Therapeutics received a thumb’s up from the European Commission for its Fabry disease therapeutic Galafold for long-term treatment of adults and adolescents aged 16 years and older with a confirmed diagnosis of Fabry disease and who have an amenable mutation. — Amicus Therapeutics
Roche got a greenlight from the European Commission for its MabThera for subcutaneous version of its treatment for chronic lymphocytic leukemia, MabThera, for people who were previously untreated and relapsed. — PharmaTimes
Can an implant wean addicts off of opioids? — CNN
Survey on the Healthcare Financial Landscape Offers a Roadmap for Stakeholders
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
PAYERS-PROVIDERS
Is a clinical decision support backlash brewing? — The Wall Street Journal
TECHNOLOGY
The College of Healthcare Information Executives has created the CHIME Cybersecurity Center and Program Office. The center will lead efforts to improve information sharing, develop and spread best practices, and encourage greater collaboration across the industry and with federal agencies. — CHIME
The CEO of digital health startup ProofPilot talks about the challenge of balancing expectations of investors with expectations of customers. — Venture Beat
A LITTLE BIT EXTRA
Bloomberg embraces gaming for its latest 404 error message.
Photo: Flickr